These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 38047701)

  • 1. Pharmacokinetic and pharmacodynamic evaluation of the atypical tetracyclines chelocardin and amidochelocardin in murine infection models.
    Rox K; Jansen R; Lukežič T; Greweling-Pils M; Herrmann J; Miethke M; Hüttel S; Hennessen F; Abou Fayad A; Holzhausen C; Lundberg CV; Teague J; Sudarman E; Bülter L; Hesterkamp T; Stadler M; Brönstrup M; Müller R
    Microbiol Spectr; 2024 Jan; 12(1):e0128923. PubMed ID: 38047701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of the Atypical Tetracyclines Chelocardin and Amidochelocardin with Renal Drug Transporters.
    Rox K; Kühne A; Herrmann J; Jansen R; Hüttel S; Bernecker S; Hagos Y; Brönstrup M; Stadler M; Hesterkamp T; Müller R
    ACS Pharmacol Transl Sci; 2024 Jul; 7(7):2093-2109. PubMed ID: 39022358
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Zhao M; Lepak AJ; Marchillo K; VanHecker J; Andes DR
    Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28416552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterologous expression of the atypical tetracycline chelocardin reveals the full set of genes required for its biosynthesis.
    Lukežič T; Pikl Š; Zaburannyi N; Remškar M; Petković H; Müller R
    Microb Cell Fact; 2020 Dec; 19(1):230. PubMed ID: 33341113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amidochelocardin Overcomes Resistance Mechanisms Exerted on Tetracyclines and Natural Chelocardin.
    Hennessen F; Miethke M; Zaburannyi N; Loose M; Lukežič T; Bernecker S; Hüttel S; Jansen R; Schmiedel J; Fritzenwanker M; Imirzalioglu C; Vogel J; Westermann AJ; Hesterkamp T; Stadler M; Wagenlehner F; Petković H; Herrmann J; Müller R
    Antibiotics (Basel); 2020 Sep; 9(9):. PubMed ID: 32962088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutropenic Rat Thigh Infection Model for Evaluation of the Pharmacokinetics/Pharmacodynamics of Anti-Infectives.
    Yedle R; Reniguntla MK; Puttaswamy R; Puttarangappa P; Hiremath S; Nanjundappa M; Jayaraman R
    Microbiol Spectr; 2023 Aug; 11(4):e0013323. PubMed ID: 37260385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and Pharmacodynamics of Fosfomycin and Its Activity against Extended-Spectrum-β-Lactamase-, Plasmid-Mediated AmpC-, and Carbapenemase-Producing Escherichia coli in a Murine Urinary Tract Infection Model.
    Zykov IN; Samuelsen Ø; Jakobsen L; Småbrekke L; Andersson DI; Sundsfjord A; Frimodt-Møller N
    Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29581117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual mechanism of action of the atypical tetracycline chelocardin.
    Stepanek JJ; Lukežič T; Teichert I; Petković H; Bandow JE
    Biochim Biophys Acta; 2016 Jun; 1864(6):645-654. PubMed ID: 26969785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Semisynthesis and biological evaluation of amidochelocardin derivatives as broad-spectrum antibiotics.
    Grandclaudon C; Birudukota NVS; Elgaher WAM; Jumde RP; Yahiaoui S; Arisetti N; Hennessen F; Hüttel S; Stadler M; Herrmann J; Miethke M; Hartmann RW; Müller R; Hirsch AKH; Brönstrup M
    Eur J Med Chem; 2020 Feb; 188():112005. PubMed ID: 31911294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clostridioides difficile Modifies its Aromatic Compound Metabolism in Response to Amidochelocardin-Induced Membrane Stress.
    Brauer M; Hotop SK; Wurster M; Herrmann J; Miethke M; Schlüter R; Dittmann S; Zühlke D; Brönstrup M; Lalk M; Müller R; Sievers S; Bernhardt J; Riedel K
    mSphere; 2022 Oct; 7(5):e0030222. PubMed ID: 35993700
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Zhou YF; Tao MT; He YZ; Sun J; Liu YH; Liao XP
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29038275
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Lepak AJ; Zhao M; VanScoy B; Taylor DS; Ellis-Grosse E; Ambrose PG; Andes DR
    Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28396549
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Zhao M; Lepak AJ; Marchillo K; VanHecker J; Andes DR
    Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29987156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of Omadacycline against Escherichia coli in a Mouse Urinary Tract Infection Model.
    Singh KV; Murray BE
    Antimicrob Agents Chemother; 2021 Jun; 65(7):e0026921. PubMed ID: 33972239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ciprofloxacin Pharmacokinetics/Pharmacodynamics against Susceptible and Low-Level Resistant Escherichia coli Isolates in an Experimental Ascending Urinary Tract Infection Model in Mice.
    Jakobsen L; Lundberg CV; Frimodt-Møller N
    Antimicrob Agents Chemother; 2020 Dec; 65(1):. PubMed ID: 33106267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and pharmacodynamics of enrofloxacin treatment of Escherichia coli in a murine thigh infection modeling.
    Liu X; Yang Q; Fan Y; Du Y; Lei L; Wang D; Liu Y
    BMC Vet Res; 2021 Jun; 17(1):212. PubMed ID: 34107961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eravacycline Pharmacokinetics and Challenges in Defining Humanized Exposure In Vivo.
    Thabit AK; Monogue ML; Nicolau DP
    Antimicrob Agents Chemother; 2016 Aug; 60(8):5072-5. PubMed ID: 27353264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacodynamics of Temocillin in Neutropenic Murine Infection Models.
    Muller AE; Raaphorst M; van der Meijden A; de Winter BCM; Meletiadis J; van den Berg S
    Antimicrob Agents Chemother; 2023 Feb; 67(2):e0143322. PubMed ID: 36692307
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Zhou YF; Tao MT; Huo W; Liao XP; Sun J; Liu YH
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28264844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chelocardin-inducible resistance in Escherichia coli bearing R plasmids.
    Chabbert YA; Scavizzi MR
    Antimicrob Agents Chemother; 1976 Jan; 9(1):36-41. PubMed ID: 769671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.